1309839-72-2Relevant academic research and scientific papers
Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
Jones, Lyn H.,Baldock, Helen,Bunnage, Mark E.,Burrows, Jane,Clarke, Nick,Coghlan, Michele,Entwistle, David,Fairman, David,Feeder, Neil,Fulton, Craig,Hilton, Laura,James, Kim,Jones, Rhys M.,Kenyon, Amy S.,Marshall, Stuart,Newman, Sandra D.,Osborne, Rachel,Patel, Sheena,Selby, Matthew D.,Stuart, Emilio F.,Trevethick, Michael A.,Wright, Karen N.,Price, David A.
, p. 2759 - 2763 (2011/06/22)
This paper describes the successful design and development of dual pharmacology β-2 agonists-M3 antagonists, for the treatment of chronic obstructive pulmonary disorder using the principles of 'inhalation by design'. A key feature of this work is the comb
